CClinicalTrials.gg
CompletedNCT07324395Updated Jan 7, 2026

Posterior Chain Responses to Gastrocnemius DOMS

An interventional study of Gastrocnemius DOMS Induction Protocol in Delayed Onset Muscle Soreness (DOMS) and Healthy, sponsored by Ebru Aloğlu Çiftçi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Ebru Aloğlu Çiftçi · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Dec 2022, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn how delayed onset muscle soreness (DOMS) in the calf muscle (gastrocnemius) affects the muscles of the posterior chain and physical performance in healthy young adults. The main questions the study aims to answer are:

Does DOMS in the calf muscle change the biomechanical properties (tone, stiffness, elasticity) of other muscles in the posterior chain?

Does DOMS lower trunk endurance, muscle strength, balance, or jump performance?

Participants will:

Take part in a gastrocnemius exercise protocol designed to safely create DOMS

Complete repeated assessments at baseline, immediately after exercise, and at 24, 48, and 72 hours

Have their muscle properties measured with a handheld device

Complete trunk endurance tests, muscle strength tests, balance tests, and a vertical jump test

Provide a blood sample to measure creatine kinase (a marker of muscle damage)

This research may help clinicians better understand how soreness in one muscle can influence the whole posterior chain and may guide safer training and recovery strategies.

Read the detailed description

This prospective repeated-measures clinical trial includes healthy adults aged 18-25 years. DOMS will be induced using a standardized exercise protocol targeting the gastrocnemius muscle. Outcome measures will be collected at five time points: baseline, immediately after the DOMS-inducing exercise, and 24, 48, and 72 hours post-exercise.

Primary outcomes include muscle biomechanical properties such as muscle tone, stiffness, elasticity, relaxation, and creep, measured using a digital myotonometer. Trunk endurance is also assessed as a primary outcome because of the posterior chain's role in load transfer and stabilization.

Secondary outcomes include:

Muscle strength

Dynamic balance performance

Vertical jump height

Pain pressure threshold

Serum creatine kinase levels to confirm muscle damage

To reduce assessment bias, each assessor is responsible for only one measurement type and is blinded to the DOMS-induction procedure. All assessments occur at the same time points for all participants.

The study aims to provide new information about how localized muscle soreness affects chain-related muscle behavior and functional performance. Findings may contribute to improved injury-prevention, training, and rehabilitation strategies, especially for populations exposed to high mechanical load.

02

Conditions studied

  • Delayed Onset Muscle Soreness (DOMS)
  • Healthy

Keywords

  • Delayed onset muscle soreness
  • posterior chain muscles
  • Trunk Endurance
  • muscle stiffness
03

In context

Lead sponsor

Ebru Aloğlu Çiftçi is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • The study included 14 volunteers aged 18-25 with a resting heart rate between 50 and 90 beats per minute who were right-handed.

Exclusion criteria

Exclusion Criteria:

  • Individuals who had undergone lower extremity injury or surgery in the past six months were excluded from the study. Those with chronic lower extremity pain or systemic or neurological diseases were also excluded. Participants with vision or hearing problems that could affect balance were excluded. Individuals who regularly used medication, smoked, consumed alcohol, or used other harmful substances were also excluded. Participants who regularly used caffeine or vitamin C supplements or who had an exercise habit were also excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    DOMS Induction Arm

    Participants in this arm will complete a standardized exercise protocol designed to induce delayed onset muscle soreness (DOMS) in the gastrocnemius muscle. All assessments will be performed at baseline, immediately after the DOMS protocol, and at 24, 48, and 72 hours.

    Other: Gastrocnemius DOMS Induction Protocol

Interventions

  • OtherGastrocnemius DOMS Induction Protocol

    Participants will complete an eccentric exercise protocol to safely induce delayed onset muscle soreness (DOMS) in the gastrocnemius muscle. The protocol includes: Exercise performed bilaterally, starting with the dominant leg Three sets of eccentric heel-lowering movements A 5-minute rest period between sets Participants place the foot on a step and lower the heel for 3 seconds using eccentric contraction The heel is lowered until no further downward motion is possible The opposite leg is used only to lift the body back to the starting position in 1 second A metronome set to 60 beats per minute is used to control movement speed Each set ends when the participant can no longer maintain the required tempo Participants are instructed to avoid physical activity and not take any pain-relieving medication during the 72-hour follow-up period. Intervention Model Description: All participants receive the same DOMS induction protocol.

06

What researchers measure

Primary outcomes

  1. Muscle Biomechanical Properties (Muscle Tone)

    Muscle tone (F) will be assessed using the MyotonPRO device. Measurements will be recorded in Hertz (Hz). Measurements will be taken three times for each muscle segment, and the average value will be calculated. Standardized anatomical landmarks were used for each muscle: Gastrocnemius: measured at the thickest part of the medial head, approximately 10 cm below the popliteal crease. The location was confirmed with a tape measure to account for individual differences. Hamstrings: measured with the participant in a prone position, at the midpoint between the ischial tuberosity and the fibular head. Gluteus maximus: measured at the thickest portion of the muscle identified by palpation while the participant was prone. Erector spinae: measured 2.5 cm lateral to the L5 spinous process in the prone position. Measurement points were marked on the skin to en

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  2. Muscle Biomechanical Properties (Muscle Stiffness)

    Muscle stiffness (S) will be assessed using the MyotonPRO device. Results will be reported in Newtons per meter (N/m). Measurements will be taken three times for each muscle segment, and the average value will be calculated. Standardized anatomical landmarks were used for each muscle: Gastrocnemius: measured at the thickest part of the medial head, approximately 10 cm below the popliteal crease. The location was confirmed with a tape measure to account for individual differences. Hamstrings: measured with the participant in a prone position, at the midpoint between the ischial tuberosity and the fibular head. Gluteus maximus: measured at the thickest portion of the muscle identified by palpation while the participant was prone. Erector spinae: measured 2.5 cm lateral to the L5 spinous process in the prone position. Measurement points were marked on the skin to en

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  3. Muscle Biomechanical Properties (Muscle Elasticity)

    Muscle elasticity will be characterized by the logarithmic decrement (D) measured using the MyotonPRO device. This is a unitless (relative) value representing the ability of the muscle to restore its shape after deformation. Measurements will be taken three times for each muscle segment, and the average value will be calculated. Standardized anatomical landmarks were used for each muscle: Gastrocnemius: measured at the thickest part of the medial head, approximately 10 cm below the popliteal crease. The location was confirmed with a tape measure to account for individual differences. Hamstrings: measured with the participant in a prone position, at the midpoint between the ischial tuberosity and the fibular head. Gluteus maximus: measured at the thickest portion of the muscle identified by palpation while the participant was prone. Erector spinae: measured 2.5 cm lateral to the L5 spinous process in the prone position. Measurement points were marked on the skin to en

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  4. Muscle Biomechanical Properties (Muscle Relaxation Time)

    Mechanical stress relaxation time (R) will be measured using the MyotonPRO to assess the time the muscle takes to return to rest following deformation. Results will be reported in milliseconds (ms). Measurements will be taken three times for each muscle segment, and the average value will be calculated. Standardized anatomical landmarks were used for each muscle: Gastrocnemius: measured at the thickest part of the medial head, approximately 10 cm below the popliteal crease. The location was confirmed with a tape measure to account for individual differences. Hamstrings: measured with the participant in a prone position, at the midpoint between the ischial tuberosity and the fibular head. Gluteus maximus: measured at the thickest portion of the muscle identified by palpation while the participant was prone. Erector spinae: measured 2.5 cm lateral to the L5 spinous process in the prone position. Measurement points were marked on the skin to en

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  5. Muscle Biomechanical Properties (Muscle Creep)

    Muscle creep will be assessed as the ratio of relaxation and deformation time (Creep (C)) using the MyotonPRO device. This parameter is a relative unit and indicates viscoelastic behavior of the muscle. Measurements will be taken three times for each muscle segment, and the average value will be calculated. Standardized anatomical landmarks were used for each muscle: Gastrocnemius: measured at the thickest part of the medial head, approximately 10 cm below the popliteal crease. The location was confirmed with a tape measure to account for individual differences. Hamstrings: measured with the participant in a prone position, at the midpoint between the ischial tuberosity and the fibular head. Gluteus maximus: measured at the thickest portion of the muscle identified by palpation while the participant was prone. Erector spinae: measured 2.5 cm lateral to the L5 spinous process in the prone position. Measurement points were marked on the skin to en

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  6. Trunk Endurance Assessment (Sorenson Test)

    Sorenson Test: Participants lay prone with their pelvis at the table edge and ankles secured. They held their upper body in a horizontal position, and the time they could maintain the position was recorded. The test ended when the participant could no longer keep the trunk horizontal.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  7. Trunk Endurance Assessment (Sit-up Test)

    Sit-up Test: Participants sat with knees flexed at 90° and their upper body positioned at a 60° angle. Arms were crossed over the chest. Time was recorded until the participant's upper body dropped below the 60° angle.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  8. Trunk endurance assessment (Side Bridge Test-Right and Left)

    Participants lay on their side and lifted their hips to form a straight line with the torso. The duration they could maintain this position was recorded. The test was performed on both sides.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

Secondary outcomes

  1. Muscle Strength

    Muscle strength of the gastrocnemius, hamstrings, and gluteus maximus was measured using a Lafayette hand-held dynamometer with the "make test" method. The results measured with the dynamometer were recorded in Newtons. Participants pushed against the fixed device with maximal effort for 3-5 seconds in standardized positions: Gastrocnemius: foot pushing against the wall in a reverse sit-up position. Hamstrings: prone position with the knee at 30° flexion; force applied toward knee flexion. Gluteus maximus: prone with knee at 90° flexion; force applied during hip extension.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  2. Dynamic balance performance

    Dynamic balance was assessed using the Y-Balance Test. Participants stood barefoot on the central platform and reached in the anterior, posteromedial, and posterolateral directions while keeping their hands on their hips. Each direction included four practice trials and three test trials for each leg. Reach distances were recorded in centimeters and normalized to leg length. A composite score was calculated using the three reach directions. Leg dominance was determined by asking which leg the participant would use to kick a ball.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  3. Vertical jump test

    To assess participants' functional performance, a vertical jump test was administered. During the test, participants were asked to jump as high as possible with both feet in front of a platform fixed to the wall. First, the participant's normal arm length was determined by touching the highest point they could reach. Then, participants performed two trials to achieve the highest jump distance, and the best value was recorded. The difference between the jump distance and the normal arm length, calculated in centimeters, was used as a performance measure.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

Other outcomes

  1. Creatine Kinase

    Creatine kinase (CK) levels were measured to confirm muscle damage. Blood samples were collected into heparin tubes and then centrifuged to separate the serum. Serum samples were stored at -80°C until analysis. CK levels were measured using a standard ELISA kit. During the test, serum samples and standards were placed into antibody-coated wells, followed by incubation with biotin and Streptavidin-HRP to form an immune complex. After washing, color-developing solutions were added, and the final color change was measured at 450 nm using a microplate reader. Higher CK values indicate greater muscle damage.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  2. Pain pressure threshold

    The pain pressure threshold (PPT) was assessed using a dolorimeter device. The dolorimeter (Baseline Push-Pull Force Gauge, New York, USA) was applied vertically to the medial and lateral gastrocnemius muscles, increasing by 1 kg/cm² every three seconds until the participant felt pain. This procedure was repeated three times. A minimum of 20 seconds was allowed between measurements, and the average of the measurements was taken. The validity and reliability of the method have been demonstrated in the literature, with a Cronbach's alpha value of 0.84 reported, indicating internal consistency.

    Time frame: Baseline, 24 hours post-DOMS, 48 hours post-DOMS, and 72 hours post-DOMS

  3. Physical Activity Level (IPAQ-Short Form)

    Physical activity levels were assessed at baseline using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). The questionnaire consists of 7 items asking participants about the total time spent in light, moderate, and vigorous physical activity during the previous 7 days. Activity scores were calculated by multiplying the time reported for each activity level by its corresponding metabolic equivalent (MET value: 3.3 for light, 4.0 for moderate, and 8.0 for vigorous activity). Total physical activity was recorded as MET-minutes per week. This measure was used as a sociodemographic characteristic and was not reassessed during follow-up.

    Time frame: Baseline only (assessed once before the DOMS protocol)

07

Study locations

1 site
  • Istinye University Topkapi Campus, Maltepe, Teyyareci Sami St. No:3,
    Istanbul, Zeytinburnu 34010, Turkey (Türkiye)
08

References and documents

Publications

  • Baird MF, Graham SM, Baker JS, Bickerstaff GF. Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab. 2012;2012:960363. doi: 10.1155/2012/960363. Epub 2012 Jan 11. PubMed 22288008 ↗

Individual participant data

Plan to share: No — IPD will not be shared because the ethics approval for this study does not allow external sharing of participant data, even in de-identified form.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07324395
Lead sponsor
Ebru Aloğlu Çiftçi
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Ebru Aloğlu Çiftçi (PhD student, Istinye University) — Sponsor-investigator
First posted
Jan 7, 2026
Start date
Dec 20, 2022
Primary completion
Mar 20, 2025
Completion
Apr 25, 2025
Last update
Jan 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion